SCHEMBL484971

SCHEMBL484971

C=C(C)C(=O)OC(C)C(C)O

nearest known ligand 0.45

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.45
ALDH1A1 P00352 2/20 0.44
THRB P10828 1/20 0.33
TDP1 Q9NUW8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5179633 1.00 TSHR (0.45) TSHRALDH1A1THRBTDP1
SCHEMBL4734217 0.87 TSHR (0.50) TSHRALDH1A1THRBTDP1
SCHEMBL5177443 0.87 TSHR (0.50) TSHRALDH1A1THRBTDP1
SCHEMBL9070457 0.86 TSHR (0.42) TSHRALDH1A1THRB
SCHEMBL1354723 0.86 TSHR (0.45) TSHRALDH1A1THRBTDP1
SCHEMBL8965613 0.86 TSHR (0.45) TSHRALDH1A1THRBTDP1
SCHEMBL8967389 0.84 TSHR (0.43) TSHRALDH1A1THRBTDP1
SCHEMBL8966142 0.83 TSHR (0.46) TSHRALDH1A1THRBTDP1
SCHEMBL11053273 0.83 TSHR (0.46) TSHRALDH1A1THRBTDP1
SCHEMBL8965826 0.82 TSHR (0.42) TSHRALDH1A1THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 243 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024018039-A1 ACRYLIC COPOLYMERS IMPARTING LOW YELLOWING AFTER PHOTOCURING ARKEMA FRANCE (FR) 2024-01-25 WO claimed
WO-2024018041-A1 OLIGOMERS COMPRISING POLYMERIZED HIGH-TG MONOMERS ARKEMA FRANCE (FR) 2024-01-25 WO claimed
WO-2023237595-A1 COMPOSITION BASED ON A POLYMERIZABLE COMPONENT AND A THIXOTROPIC ADDITIVE ARKEMA FRANCE (FR) 2023-12-14 WO claimed
EP-3105286-B1 PROCESS FOR CURING (METH)ACRYLATE-CONTAINING UP OR VE RESIN AKZO NOBEL CHEMICALS INT BV (NL) 2018-04-11 EP claimed
EP-3105286-A1 PROCESS FOR CURING (METH)ACRYLATE-CONTAINING UP OR VE RESIN Akzo Nobel Chemicals International B.V. (NL) 2016-12-21 EP claimed
US-20160355664-A1 PROCESS FOR CURING (METH)ACRYLATE-CONTAINING UP OR VE RESIN AKZO NOBEL CHEMICALS INTERNATIONAL B.V. (NL) 2016-12-08 US claimed
WO-2015121178-A1 PROCESS FOR CURING (METH)ACRYLATE-CONTAINING UP OR VE RESIN AKZO NOBEL CHEMICALS INTERNATIONAL B.V. (NL) 2015-08-20 WO claimed
US-8618194-B2 Resin mortar suitable for construction purposes, especially for chemical anchoring HILTI AKTIENGESELLSCHAFT (LI) 2013-12-31 US claimed
EP-2357162-B1 Resin mortar suitable for construction purposes, especially for chemical anchoring HILTI AG (LI) 2012-09-05 EP claimed
US-20110201726-A1 RESIN MORTAR SUITABLE FOR CONSTRUCTION PURPOSES, ESPECIALLY FOR CHEMICAL ANCHORING HILTI AKTIENGESELLSCHAFT (LI) 2011-08-18 US claimed
EP-2357162-A1 Resin mortar suitable for construction purposes, especially for chemical anchoring HILTI Aktiengesellschaft (LI) 2011-08-17 EP claimed
US-5851967-A Dispersant viscosity index improving additive for lubricating oils EVONIK ROHMAX ADDITIVES GMBH (DE) 1998-12-22 US claimed
US-12637809-B2 Oil-resistant agent composition DAIKIN INDUSTRIES, LTD. (JP) 2026-05-26 US disclosed
CN-122094989-A Polymer, water repellent, fiber product and method for producing fiber product 2026-05-26 CN disclosed
EP-4726101-A1 WATER REPELLENT COMPOSITION AND METHOD FOR PRODUCING SAME Daikin Industries, Ltd. (JP) 2026-04-15 EP disclosed
EP-4345138-B1 OIL-RESISTANT AGENT COMPOSITION DAIKIN IND LTD (JP) 2025-12-03 EP disclosed
WO-2000006243-A2 ABSORBABLE BRACHYTHERAPY AND CHEMOTHERAPY DELIVERY DEVICES AND METHODS INNERDYNE, INC. (US) 2000-02-10 WO disclosed
EP-0758268-A4 POLYMER CEMENT COMPOSITIONS AND INITIATORS FOR USE IN THE PREPARATION THEREOF UNIV CALIFORNIA (US) 1999-04-28 EP disclosed
EP-0758268-A1 POLYMER CEMENT COMPOSITIONS AND INITIATORS FOR USE IN THE PREPARATION THEREOF THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1997-02-19 EP disclosed
WO-1995030480-A2 INITIATORS OF TERTIARY AMINE/PEROXIDE AND POLYMER THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1995-11-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12637809-B2 Oil-resistant agent composition SLC11A2, HAO2, ALOX12 TSHR 3346/4885ALDH1A1 2698/4885THRB 3043/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.